» Articles » PMID: 2209707

Detection of Interleukin 8 Biological Activity in Synovial Fluids from Patients with Rheumatoid Arthritis and Production of Interleukin 8 MRNA by Isolated Synovial Cells

Overview
Journal Eur J Immunol
Date 1990 Sep 1
PMID 2209707
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of neutrophils in the synovial joint of patients with rheumatoid arthritis (RA) is thought to be due to the activity of chemotactic factors released by activated cells in the joint. We have shown in this report, for the first time, the abundance of one such factor, interleukin 8 (IL 8), in the synovial fluid of patients both with RA and other non-RA joint diseases, and the spontaneous production of IL 8 mRNA by RA synovial cells in culture. There was no correlation between the levels of chemotactic activity and IL 8 protein, suggesting that other factors with similar neutrophil chemotactic activity are also present in the synovial fluid exudate. In support of this concept neither the level of chemotactic activity nor IL 8 protein levels correlated with neutrophil or leukocyte infiltration, indicating that the mechanism of migration into the inflammatory environment of the joint is complex. Such migration is likely to be due to a number of chemotactic signals in addition to IL 8, which may either synergize with, or inhibit, the action of IL 8.

Citing Articles

How Neutrophils Shape the Immune Response: Reassessing Their Multifaceted Role in Health and Disease.

Shafqat A, Khan J, Alkachem A, Sabur H, Alkattan K, Yaqinuddin A Int J Mol Sci. 2023; 24(24).

PMID: 38139412 PMC: 10744338. DOI: 10.3390/ijms242417583.


Expression of CXCL8 (IL-8) in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia Patients.

Pandey S, Singh R, Habib N, Singh V, Kushwaha R, Tripathi A Cureus. 2023; 15(9):e45929.

PMID: 37885528 PMC: 10599407. DOI: 10.7759/cureus.45929.


Brensocatib (an oral, reversible inhibitor of dipeptidyl peptidase-1) attenuates disease progression in two animal models of rheumatoid arthritis.

McDonald P, Leifer F, Basso J, Lasala D, Li D, Chen K Front Immunol. 2023; 14:1231047.

PMID: 37638021 PMC: 10451067. DOI: 10.3389/fimmu.2023.1231047.


The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention.

Cambier S, Gouwy M, Proost P Cell Mol Immunol. 2023; 20(3):217-251.

PMID: 36725964 PMC: 9890491. DOI: 10.1038/s41423-023-00974-6.


System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.

Yan C, Niu Y, Li F, Zhao W, Ma L J Transl Med. 2022; 20(1):455.

PMID: 36199146 PMC: 9533512. DOI: 10.1186/s12967-022-03632-z.